WHO ICTRP trial

Randomized phase II clinical study on preventive effects of GPS, healthy food on…

JPRN-UMIN000002343 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-UMIN000002343
Public title Randomized phase II clinical study on preventive effects of GPS, healthy food on the incidence of infection cases in stomach and colon cancer patients before and after the abdominal surgery
Scientific title Randomized phase II clinical study on preventive effects of GPS, healthy food on the incidence of infection cases in stomach and colon cancer patients before and after the abdominal surgery - Preventive effects of GPS on the incidence of infection cases in cancer patients before and after surgery
Primary sponsor Research institute of cancer chemotherapy
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase Phase II
Countries Japan
Conditions stomach and colon cancer patients
Interventions GPS group 250mg of GPS (a cupsel contain 125mg of GPS) are orally taken continuously for 3 days before operation and for 27days after opperation.
Registration date Aug 17, 2009
Target size 200
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations